David M Ribnicky1, Diana E Roopchand2, Alexander Poulev2, Peter Kuhn2, Andrew Oren2, William T Cefalu3, Ilya Raskin2. 1. Rutgers, The State University of New Jersey, School of Environmental and Biological Sciences, New Brunswick, New Jersey, USA. Electronic address: Ribnicky@aesop.rutgers.edu. 2. Rutgers, The State University of New Jersey, School of Environmental and Biological Sciences, New Brunswick, New Jersey, USA. 3. Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Abstract
OBJECTIVE: Scientifically validated food-based interventions are a practical means of addressing the epidemic of metabolic syndrome. An ethanolic extract of Artemisia dracunculus L. (PMI-5011) containing bioactive polyphenols, such as 2', 4'-dihydroxy-4-methoxydihydrochalcone (DMC-2), improved insulin resistance in vitro and in vivo. Plant polyphenols are concentrated and stabilized when complexed to protein-rich matrices, such as soy protein isolate (SPI), which act as effective food-based delivery vehicles. The aim of this study was to compare the bioaccessibility, bioavailability, and efficacy of polyphenols extracted from A. dracunculus and delivered as PMI-5011 (ethanolic extract alone), formulated with the non-food excipient Gelucire(®), (5011- Gelucire), or sorbed to SPI (5011-Nutrasorb(®)). METHODS: PMI-5011, 5011-Gelucire or 5011-Nutrasorb each containing 162 μg of DMC-2 was delivered to the TNO intestinal model-1 of the human upper gastrointestinal tract to compare the effect of delivery vehicle on DMC-2 bioaccessibility. C57BL6/J mice were orally administered 5011-Nutrasorb or PMI-5011 to compare effects of polyphenol-protein complexation on acute hypoglycemic activity and bioavailability of DMC-2 in serum. RESULTS: At 500 mg/kg, 5011-Nutrasorb and PMI-5011 had similar hypoglycemic activity in a high-fat diet-induced diabetes mouse model despite the fact that 5011-Nutrasorb delivered 15 times less DMC-2 (40 versus 600 μg/kg). This can be partially explained by eight times greater DMC-2 absorption into serum from 5011-Nutrasorb than from PMI-5011. TNO intestinal model-1 experiments confirmed higher total bioaccessibility of DMC-2 in vitro when delivered in 5011-Nutrasorb (50.2%) or Gelucire-5011 (44.4%) compared with PMI-5011 (27.1%; P = 0.08). CONCLUSION: Complexation with soy protein makes antidiabetic A. dracunculus polyphenols more bioavailable and bioaccessible.
OBJECTIVE: Scientifically validated food-based interventions are a practical means of addressing the epidemic of metabolic syndrome. An ethanolic extract of Artemisia dracunculus L. (PMI-5011) containing bioactive polyphenols, such as 2', 4'-dihydroxy-4-methoxydihydrochalcone (DMC-2), improved insulin resistance in vitro and in vivo. Plant polyphenols are concentrated and stabilized when complexed to protein-rich matrices, such as soy protein isolate (SPI), which act as effective food-based delivery vehicles. The aim of this study was to compare the bioaccessibility, bioavailability, and efficacy of polyphenols extracted from A. dracunculus and delivered as PMI-5011 (ethanolic extract alone), formulated with the non-food excipient Gelucire(®), (5011- Gelucire), or sorbed to SPI (5011-Nutrasorb(®)). METHODS:PMI-5011, 5011-Gelucire or 5011-Nutrasorb each containing 162 μg of DMC-2 was delivered to the TNO intestinal model-1 of the human upper gastrointestinal tract to compare the effect of delivery vehicle on DMC-2 bioaccessibility. C57BL6/J mice were orally administered 5011-Nutrasorb or PMI-5011 to compare effects of polyphenol-protein complexation on acute hypoglycemic activity and bioavailability of DMC-2 in serum. RESULTS: At 500 mg/kg, 5011-Nutrasorb and PMI-5011 had similar hypoglycemic activity in a high-fat diet-induced diabetesmouse model despite the fact that 5011-Nutrasorb delivered 15 times less DMC-2 (40 versus 600 μg/kg). This can be partially explained by eight times greater DMC-2 absorption into serum from 5011-Nutrasorb than from PMI-5011. TNO intestinal model-1 experiments confirmed higher total bioaccessibility of DMC-2 in vitro when delivered in 5011-Nutrasorb (50.2%) or Gelucire-5011 (44.4%) compared with PMI-5011 (27.1%; P = 0.08). CONCLUSION: Complexation with soy protein makes antidiabetic A. dracunculuspolyphenols more bioavailable and bioaccessible.
Authors: Diana E Roopchand; Christian G Krueger; Kristin Moskal; Bertold Fridlender; Mary Ann Lila; Ilya Raskin Journal: Food Chem Date: 2013-06-21 Impact factor: 7.514
Authors: David M Ribnicky; Peter Kuhn; Alexander Poulev; Sithes Logendra; Aamir Zuberi; William T Cefalu; Ilya Raskin Journal: Int J Pharm Date: 2008-11-25 Impact factor: 5.875
Authors: David M Ribnicky; Alexander Poulev; Joseph O'Neal; Gary Wnorowski; Dolores E Malek; Ralf Jäger; Ilya Raskin Journal: Food Chem Toxicol Date: 2004-04 Impact factor: 6.023
Authors: Mary H Grace; David M Ribnicky; Peter Kuhn; Alexander Poulev; Sithes Logendra; Gad G Yousef; Ilya Raskin; Mary Ann Lila Journal: Phytomedicine Date: 2009-03-20 Impact factor: 5.340
Authors: David C Nieman; Nicholas D Gillitt; Amy M Knab; R Andrew Shanely; Kirk L Pappan; Fuxia Jin; Mary Ann Lila Journal: PLoS One Date: 2013-08-15 Impact factor: 3.240
Authors: Yongmei Yu; Charlotte Simmler; Peter Kuhn; Alexander Poulev; Ilya Raskin; David Ribnicky; Z Elizabeth Floyd; Guido F Pauli Journal: J Nat Prod Date: 2019-12-09 Impact factor: 4.050
Authors: Jun Wang; Adelaida Esteban Fernández; Simoni Tiano; Jing Huang; Elizabeth Floyd; Alexander Poulev; David Ribnicky; Giulio M Pasinetti Journal: Oxid Med Cell Longev Date: 2018-05-13 Impact factor: 6.543